Anand Padmanabhan: A New Concise Nutshell Review of MGTS as an Emerging Thrombophilia
Anand Padmanabhan, Professor and Clinician-Investigator at Mayo Clinic, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“We are excited to share our new ‘nutshell’ review on a new thrombotic condition Monoclonal Gammopathy of Thrombotic Significance (MGTS)—a concise (~1000 words) and accessible overview of this emerging thrombophilia.
Congratulations to the authors Adam Kanack, Emily Armstrong, and David Murray on this excellent work!
MGTS is a rapidly evolving entity that we first described a few years ago, and our understanding continues to grow. This review highlights three key subtypes:
- HIT-like
- VITT-like
- Non-HIT/VITT-like
Recognizing these distinct phenotypes is critical—accurate diagnosis is the first step toward appropriate, targeted treatment.
We hope this review helps clinicians and researchers better identify and manage this often debilitating disorder.
As the field evolves, we anticipate refinements in classification and management.
Feel free to reach out with questions or to discuss further.”
Title: Monoclonal gammopathy of thrombotic significance in a nutshell
Authors: Adam J. Kanack, Emily E. Mauch, David L. Murray, Anand Padmanabhan
Read the Full Article on British Journal of Haematology

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines